0000886163-19-000080.txt : 20190514
0000886163-19-000080.hdr.sgml : 20190514
20190514195651
ACCESSION NUMBER: 0000886163-19-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOZARICH JOHN W
CENTRAL INDEX KEY: 0001223000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 19824671
MAIL ADDRESS:
STREET 1: 10275 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-05-14
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001223000
KOZARICH JOHN W
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2019-05-14
4
M
0
2500
17.88
A
28042
D
Common Stock
2019-05-14
4
S
0
2500
112.92
D
25542
D
Non-Qualified Stock Option (right to buy)
17.88
2019-05-14
2019-05-14
4
M
0
2500
0.0
D
2019-05-29
Common Stock
2500
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.24 to $113.23, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 5/29/09.
By: Charles S. Berkman For: John W. Kozarich
2019-05-14